Home LiteratureArticle Details
PMID: 2171186 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Differences in the extent of activation of Epstein-Barr virus replicative gene expression among four nonproducer cell lines stably transformed by oriP/BZLF1 plasmids.

Virology ·Vol. 178 ·No. 2 ·1990-10-00 ·Pages 345-54

Gradoville L, Grogan E, Taylor N, Miller G

Abstract

Lymphoid cell lines were established which stably carry the Epstein-Barr viral (EBV) BZLF1 gene on an extrachromosomal plasmid. These lines, which spontaneously synthesize the BZLF1 gene product, ZEBRA, were examined for expression of EBV genes which were activated by ZEBRA. Cell lines which acquired oriP plasmids without BZLF1 served as controls. The extent of activation differed among derivatives of four cell lines. X50-7 cells, which harbor a standard latent EBV, could be induced by ZEBRA to produce transforming virus; a cellular subclone of this line was induced to express EBV late antigens but did not release transforming virus. In two other cell lines, Raji and ER, ZEBRA activated only a group of early antigens. Using immunofluorescence and immunoblotting with monoclonal antibodies and Northern analysis five EBV early genes were shown to be induced in cells stably transformed by oriP/BZLF1 plasmids. ZEBRA itself was activated; thus BZLF1 is autostimulatory. Four other activated genes were components of the diffuse (EA-D) and restricted (EA-R) early antigens (BMRF1, BMLF1, BHRF1, and BORF2). Stable cell lines with extrachromosomal BZLF1 expression vectors will ultimately be useful in a variety of experiments designed to study regulation of this gene, to analyze the effects of mutations on ZEBRA protein function, and to define the full spectrum of viral and cellular genes which are activated by and interact with the ZEBRA protein.

MeSH Terms
Cell Line Cell Transformation, Viral DNA Replication DNA, Viral/biosynthesis Drug Resistance, Microbial/genetics Gene Expression Regulation, Viral Genetic Complementation Test Herpesvirus 4, Human/genetics,growth & development Humans Mutation Plasmids/genetics RNA, Messenger/metabolism Trans-Activators/genetics Transcription, Genetic Virus Replication/genetics
Chemicals
DNA, Viral RNA, Messenger Trans-Activators
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Gradoville L
Department of Epidemiology and Public Health, Yale University School of Medicine, New Haven, Connecticut 06510.
Grogan E
Taylor N
Miller G
Article Info
Journal
Virology
Abbr.
Virology
ISSN
0042-6822
Published
1990-10-00
Pages
345-54
Language
English
Region
United States
NLM ID
0110674
Subset
IM
Grants
NIAID NIH HHS · AI22959 · United States
NCI NIH HHS · CA12055 · United States
NCI NIH HHS · CA16038 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com